Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State-Reference-Cited by-同舟云学术

Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State

Published:2018-06-29 Issue:4 Volume:123 Page:443-451
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Jantas Danuta¹,Grygier Beata¹,Zatorska Justyna¹,Lasoń Władysław¹

Affiliation:

1. Department of Experimental Neuroendocrinology; Institute of Pharmacology; Polish Academy of Sciences; Kraków Poland

Funder

National Science Center, Poland

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.13041/fullpdf

Reference50 articles.

1. Metabotropic glutamate receptors: new targets for the control of tumor growth?;Nicoletti;Trends Pharmacol Sci,2007

2. Glutamate and its receptors in cancer;Stepulak;J Neural Transm (Vienna),2014

3. mGlu receptors and cancerous growth;Teh;Wiley Interdiscip Rev Membr Transp Signal,2012

4. Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications;Willard;Int J Biol Sci,2013

5. Metabotropic glutamate receptors in cancer;Yu;Neuropharmacology,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on the Neurotoxic Effects of Doxorubicin;Neurotoxicity Research;2023-06-23

2. The role of glutamate receptors in the regulation of the tumor microenvironment;Frontiers in Immunology;2023-02-01

3. Neuroprotective Effects of Necrostatin-1 Against Oxidative Stress–Induced Cell Damage: an Involvement of Cathepsin D Inhibition;Neurotoxicity Research;2020-01-21

4. Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer;Cancer Letters;2019-02